Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1998
05/12/1998US5750653 Protein, FAF1, which potentiates Fas-mediated apoptosis and uses thereof
05/12/1998US5750652 Deltex proteins
05/12/1998US5750651 Cartilage and bone-inducing proteins
05/12/1998US5750647 Oligopeptides strongly binding to monoclonal antibody mab 1h11; immunoassay standards
05/12/1998US5750571 Methods and therapeutic compositions for treating cystic fibrosis
05/12/1998US5750504 Plant extracts
05/12/1998US5750503 Administering synergistic mixture of granulocyte colony stimulating factor (g-csf) and tumor necrosis factor binding protein (tnf-bp) lacking first domain of constant region of heavy chain of human immunoglobulin igg1 or igg3
05/12/1998US5750502 Cloning, expression and uses of a secreted protein, F-spondin
05/12/1998US5750499 Antitumor
05/12/1998US5750497 Water solublity
05/12/1998US5750400 Coding sequences of the human BRCA1 gene
05/12/1998US5750398 Vector, element and method for inhibiting immune recognition
05/12/1998US5750396 Stable virus packaging cell lines
05/12/1998US5750395 DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides
05/12/1998US5750394 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
05/12/1998US5750391 Filariid nematode cysteine protease proteins
05/12/1998US5750386 Pathogen resistant
05/12/1998US5750385 Methods and compositions for regulated transcription and expression of heterologous genes
05/12/1998US5750384 L5 shuttle phasmids
05/12/1998US5750378 Method for preparing cellular fibronectin
05/12/1998US5750377 Process for preparing mammalian T cell growth factor P40
05/12/1998US5750376 In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
05/12/1998US5750375 Methods of producing secreted receptor analogs and biologically active dimerized polypeptide fusions
05/12/1998US5750374 Process for producing hydrophobic polypeptides and proteins, and fusion proteins for use in producing same
05/12/1998US5750373 Fusing gene coding a protein of interest to carboxy terminal domain of the gene coat protein of the filamentous phage m13, mutating
05/12/1998US5750371 Water-soluble mutein of FGF receptor, DNA and production thereof
05/12/1998US5750370 Genetic engineering
05/12/1998US5750369 DNA encoding a prostaglandin F28 receptor, a host cell transformed therewith and an expression product thereof
05/12/1998US5750368 Culturing an acetic acid-resistant escherichia mutant having been transformed by a recombinant plasmid-carrying gene for producing the desired substance, e.g. enzymes, motilins, polypeptide hormones, biotin, fad or carotenoids
05/12/1998US5750367 Cardiovascular
05/12/1998US5750366 Cloning and expression of gonadotropin-releasing hormone receptor
05/12/1998US5750365 Isolated nucleic acid encoding a newt acidic fibroblast growth factor (AFGF)
05/12/1998US5750361 Formation and use of prion protein (PRP) complexes
05/12/1998US5750353 Assay for non-peptide agonists to peptide hormone receptors
05/12/1998US5750350 Kit containing antibodies
05/12/1998US5750349 Diagnostic composition for alzheimer's disease
05/12/1998US5750342 Contacting mixture of nucleic acids with target comprising blood cells, fibrin clots, carotid arteries, partitioning high affinity nucleic acids from remainder of mixture, amplifying to yield mixture enriched in high affinity nucleic acids
05/12/1998US5750336 Camp = cyclic adenosine phosphate
05/12/1998US5750332 Peptomers with enhanced immunogenicity
05/12/1998US5750331 Detection of antibodies for hepatitis c with proteins
05/12/1998US5750172 Transgenic non human mammal milk
05/12/1998US5750126 Ultraviolet stable
05/12/1998US5750119 Immunotherapeutic stress protein-peptide complexes against cancer
05/12/1998US5750116 Haemophilus influenzae pilus vaccines
05/12/1998US5750115 Veterinary medicine
05/12/1998US5750114 Glycosylated glycoprotein d polypeptide
05/12/1998US5750109 Gene coding; neutralization antigen
05/12/1998US5750102 Double transfectants of the MHC genes as cellular vaccines for immuno prevention of tumor metastasis
05/12/1998US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
05/12/1998US5750078 Side effect reduction
05/12/1998US5749847 Delivery of nucleotides into organisms by electroporation
05/12/1998US5749169 Identification and selection of androgenetic haploids
05/12/1998CA2205045A1 Factors and methods for reducing biological activity of a multimeric protein and methods of screening therefor
05/12/1998CA2190056A1 Pharmaceutical composition for prophylaxis or treatment of cerebral vasospasm
05/12/1998CA1339868C Serum immunoregulatory polypeptide and uses therefor
05/07/1998WO1998019271A1 Proteome analysis for characterization of up- and down-regulated proteins in biological samples
05/07/1998WO1998019167A2 Cell stress regulated human mhc class i gene
05/07/1998WO1998019160A2 METHOD FOR THE INDIRECT DETERMINATION OF THE IN VIVO PRODUCTION OF INTERFERON OF TYPE I BY MEANS OF ANTIBODIES DIRECTED AGAINST Mx HUMAN PROTEINS
05/07/1998WO1998018966A1 Primers for amplification of brca1
05/07/1998WO1998018955A1 Assay using marked microbial host cell strains
05/07/1998WO1998018950A2 Aav-dna helper virus sequences
05/07/1998WO1998018946A1 Process for bacterial production of polypeptides
05/07/1998WO1998018945A1 Reagents and methods useful for detecting diseases of the breast
05/07/1998WO1998018943A1 Method for the oligomerisation of peptides
05/07/1998WO1998018942A2 Novel human rab proteins
05/07/1998WO1998018937A1 Microbial preparation of substances from aromatic metabolism/ii
05/07/1998WO1998018936A1 Microbial preparation of substances from aromatic metabolism/i
05/07/1998WO1998018933A1 Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
05/07/1998WO1998018932A2 Novel pesticidal toxins and nucleotide sequences which encode these toxins
05/07/1998WO1998018931A2 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998WO1998018930A2 Streptococcus pneumoniae antigens and vaccines
05/07/1998WO1998018929A1 Nucleic acid sequences encoding citrate transporter proteins
05/07/1998WO1998018928A1 Immunogenic detoxified mutant e. coli lt-a toxin
05/07/1998WO1998018927A1 Candida albicans proteins associated with virulence and hyphal formation and uses thereof
05/07/1998WO1998018926A1 Circularly permuted erythropoietin receptor agonists
05/07/1998WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998WO1998018924A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998WO1998018923A1 NOVEL flt-3 RECEPTOR AGONISTS
05/07/1998WO1998018922A1 Human phosphoprotein
05/07/1998WO1998018921A1 NEUTROKINE $g(a)
05/07/1998WO1998018920A1 cDNA FRAGMENTS OF GENE CAUSATIVE OF SPINOCEREBELLAR ATAXIA TYPE 2
05/07/1998WO1998018919A2 Gabaa receptor subunit epsilon-related protein
05/07/1998WO1998018918A1 Stable expression of triple helical proteins
05/07/1998WO1998018916A1 Human p2x purinoreceptor
05/07/1998WO1998018914A1 Soluble tie2 receptor
05/07/1998WO1998018913A1 High level of expression of ingap
05/07/1998WO1998018911A1 Human guanylate-binding proteins
05/07/1998WO1998018905A1 Extracellular expression of cellulose binding domains (cbd) using bacillus
05/07/1998WO1998018825A1 Anti-p53 single-chain antibody fragments and their uses
05/07/1998WO1998018824A1 Human tumor necrosis factor receptor-like 2
05/07/1998WO1998018823A1 Ice inhibiting peptides
05/07/1998WO1998018822A2 Novel human lim proteins
05/07/1998WO1998018821A1 Vaccines against pathogens characterized by serological cross-reaction but lacking cross-protection
05/07/1998WO1998018820A1 Methods and compositions for ricin fusion protein immunotoxins to treat cancer and autoimmune disease
05/07/1998WO1998018819A1 Purification of respiratory syncytial virus antigens
05/07/1998WO1998018818A2 Hepatitis b inhibitors
05/07/1998WO1998018817A1 Novel high-affinity salicylic acid-binding protein
05/07/1998WO1998018816A1 Peptide compositions with growth factor-like activity
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018809A1 Targeted cytolysis of cancer cells
1 ... 2393 2394 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 ... 2916